Lindsay M. Avery - Concepedia

Author

Lindsay M. Avery

Hartford Hospital

Also Known As

Lindsay Avery, Lindsay M Avery, Lindsay M. Avery

Publications

398

Citations

H-Index

Concepts

All Affiliations

Hartford Hospital Hartford Financial Services (United States)

About

Lindsay M. Avery is an author at Hartford Hospital specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	94
2	Microbiology	3	3	76
3	Pharmacology	2	2	33
4	Anesthesia	1	1	18
5	Antibiotics	1	1	16

Lindsay M. Avery

Publications

298

Citations

H-Index

Page 1

	Year	Citations
Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint Lindsay M. Avery, Joseph L. Kuti, Maja Weisser, Clinical Infectious Diseases	2018	54
Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope Lindsay M. Avery, David P. Nicolau International Journal of Antimicrobial Agents Medical MicrobiologyAntimicrobial SusceptibilityCarbapenemase-producing EnterobacteriaceaeAntimicrobial ChemotherapyMicrobiology	2018	45
Assessment of the <i>In Vivo</i> Efficacy of WCK 5222 (Cefepime-Zidebactam) against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung Infection Model Lindsay M. Avery, Kamilia Abdelraouf, David P. Nicolau Antimicrobial Agents and Chemotherapy	2018	43
<i>In Vivo</i> Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model Safa S. Almarzoky Abuhussain, Lindsay M. Avery, Kamilia Abdelraouf, Antimicrobial Agents and Chemotherapy	2018	36
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa Lindsay M. Avery, Christina Sutherland, David P. Nicolau Journal of Medical Microbiology	2019	23
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration Tomefa E. Asempa, Lindsay M. Avery, James M. Kidd, American Journal of Health-System Pharmacy	2018	21
Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration James M. Kidd, Lindsay M. Avery, Tomefa E. Asempa, Clinical Therapeutics Therapeutic Drug MonitoringPharmaceutical ScienceSelect Intravenous DrugsPharmacologyPharmacotherapy	2017	18
Comparative Evaluation of the <i>In Vitro</i> Activities of WCK 5222 (Cefepime-Zidebactam) and Combination Antibiotic Therapies against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Elias M. Mullane, Lindsay M. Avery, David P. Nicolau Antimicrobial Agents and Chemotherapy	2019	17
In vitro investigation of synergy among fosfomycin and parenteral antimicrobials against carbapenemase-producing Enterobacteriaceae Lindsay M. Avery, Christina Sutherland, David P. Nicolau Diagnostic Microbiology and Infectious Disease Antimicrobial SusceptibilityAntibioticsParenteral AntimicrobialsCarbapenemase-producing EnterobacteriaceaeAntimicrobial Therapy	2019	16
Evaluation of the in vitro activity of WCK 5222 (cefepime/zidebactam) and currently available combination therapies against single- and double-carbapenemase producing Enterobacteriaceae: Expanding the zone of hope Lindsay M. Avery, Elias M. Mullane, David P. Nicolau International Journal of Antimicrobial Agents MedicineKlebsiella PneumoniaeAntibacterial AgentMicrobiologyWck 5222	2019	15

Page 1